Bio-Rad Laboratories, Inc.
NYSE · Technology · Laboratory Analytical Instruments · Hercules, CA
BIO-B chart
What traders are saying about $BIO-B
Latest postsBio-Rad Laboratories, Inc. news
- Capillary Electrophoresis - Global Strategic Business Report: Secure Share of the $1.1 Billion Market by 2032 as Agilent, Bio-Rad, Danaher and Thermo Fisher Accelerate CE-MS Innovation
Yahoo Finance ·
- Nucleic Acid Isolation and Purification - Global Strategic Business Report: Capture the $3.9 Billion Revenue Surge by 2030 as Thermo Fisher, Qiagen, Danaher, Illumina, and Bio-Rad Battle for Share
Yahoo Finance ·
- Gene Amplification Technologies - Global Strategic Business Report: Capture $4.4B in New Revenue by 2030 as Abbott, Bio-Rad, bioMerieux, Cepheid and Becton Dickinson Battle for Share
Yahoo Finance ·
- Why Is Bio Rad Laboratories (BIO) Drawing Elliott’s Attention Now?
Yahoo Finance ·
- Bio Rad Laboratories (BIO) Stock Could Be 23% Overvalued Despite Activist Pressure
Simply Wall St ·
- How Investors Are Reacting To Bio Rad (BIO) International Revenue Surprise
Yahoo Finance ·
- Form 144 BIO-RAD LABORATORIES For: 9 November By Investing.com
Investing.com Canada ·
- Why Bio-Rad (BIO) International Revenue Trends Deserve Your Attention
Yahoo Finance ·
- Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting
Yahoo Finance ·
- Bio Rad Laboratories (BIO) Could Be 14% Overvalued After Elliott Interest And Earnings
Simply Wall St ·
- Bio-Rad Laboratories-B (BIO.B.US) will release its earnings report after the market close on November 5.
Moomoo ·
- Bio-Rad Laboratories, Inc. (BIO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
Bio-Rad Laboratories, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.58B | $2.57B | $2.67B | $2.80B |
| Net income | $759.9M | -$1.84B | -$637.3M | -$3.63B |
| Diluted EPS | $27.85 | $-65.36 | $-21.82 | $-121.79 |
| Total assets (year end) | $10.58B | $9.36B | $12.30B | $13.50B |
| Cash and equivalents (year end) | $529.8M | $488.1M | $403.8M | $434.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bio-Rad Laboratories, Inc.
- Ticker
- BIO-B (NYSE)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Hercules, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 12208
- Former names
- BIO RAD LABORATORIES INC
Frequently asked questions
What exchange is Bio-Rad Laboratories, Inc. listed on?
Bio-Rad Laboratories, Inc. trades on the NYSE under the ticker symbol BIO-B.
What industry is Bio-Rad Laboratories, Inc. in?
Bio-Rad Laboratories, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is Bio-Rad Laboratories, Inc. headquartered?
Bio-Rad Laboratories, Inc.'s business address on file with the SEC is in Hercules, CA.
When does Bio-Rad Laboratories, Inc.'s fiscal year end?
Bio-Rad Laboratories, Inc.'s fiscal year ends on December 31.
How much revenue did Bio-Rad Laboratories, Inc. report?
Bio-Rad Laboratories, Inc. reported $2.58B in revenue for calendar year 2025, according to its SEC filings.